Aesthetics
Oct 17, 2024
Oct 17, 2024
Evolution in Aesthetics: Behind the White Paper
In this episode of Skytale Insights, host Ben Hernandez sits down with Erik Haines, Managing Director, Head of Guidepoint Qsight, to discuss our recent collaboration, Evolution in Aesthetics, a white paper covering the trends and data shaping the aesthetics industry in 2023 and 2024. Together, they explore key findings, including a remarkable 236% year-over-year increase in the use of semaglutide for weight loss treatments from 2022 to 2023. Additionally, professional-grade skincare accounted for 6% of the total non-surgical aesthetics dollar spend in 2023, signaling a significant revenue growth opportunity for med spas.
The white paper also breaks down U.S. sales across various non-surgical treatment segments, where neurotoxins lead the market at 32%, followed by dermal fillers and energy-based devices, each capturing 21%. As aesthetic practices evolve, focusing on emerging areas like skincare and weight management services can help drive growth and adapt to shifting consumer demands.
Tune in to hear more key findings and learn about the strategic objectives behind releasing this valuable industry research.
Strategy and insight, right in your inbox.
Subscribe to our email list for episode updates and releases.
Also available on:
You Might Also Like
